MedTech Dive - Latest News

SEC ends probe of Illumina’s Grail acquisition

The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.

May 9, 2025 - 21:15
 0
SEC ends probe of Illumina’s Grail acquisition

The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.

Read More

Tags:

Previous Article

Yamaha looks for sax appeal among China’s ageing population

Next Article

The Ultimate Meridian, ID Bucket List: 13 Iconic Destinations to Visit

Related Posts

Ceribell wins FDA nod for algorithm to detect pediatric seizures

Ceribell wins FDA nod for algorithm to detect pediatric...

Apr 21, 2025  0

RFK’s FDA layoffs could slow safety communications, experts warn

RFK’s FDA layoffs could slow safety communications, exp...

May 6, 2025  0

Medtronic wins FDA approval for defibrillation lead

Medtronic wins FDA approval for defibrillation lead

Apr 30, 2025  0